for 55% of their total mortality [1] . The cardiovascular Background. Cardiovascular disease is now the major mortality is, however, significantly higher in the cause of death in renal transplant patients. This study Northern than in the Southern parts of Europe [2] . aimed to assess the prevalence of cardiovascular disease Thus, cardiovascular mortality rates in renal transplant in stable renal transplant patients as compared with patients in Norway are particularly high, and up to 10 the general background population, and to assess risk times higher than found in Southern Europe [3] . factors for cardiovascular disease in this patient group. Whereas in European renal transplant patients at large, Methods. A cross-sectional multicentre study compris-cardiovascular disease accounts for 36% of the total ing 406 stable renal transplant patients (age 47±16 late mortality [3] , ischaemic heart disease alone causes years, 60% males, 71% taking cyclosporin A) were as much as 53% of deaths in these patients in assessed clinically and biochemically 48 months Scandinavia [4] . (median) after transplantation and compared with the Only a few studies have compared mortality in general population. Multivariate analysis was used to patients on renal replacement therapy in general with assess the relation between cardiovascular disease and that of the background population [3] [4] [5] , and to our risk factors.
Introduction diseases in 4.4%, myeloma, systemic lupus erytemathosus or vascular renal disease in 20.6%. Diabetes mellitus was present in 21.3% of the male patients and in 13.2% of the females assessed by multivariate analysis using multiple logistic Ischaemic heart disease was defined as the presence of regression. The distribution of blood triglycerides and angina pectoris and/or a previous myocardial infarction. time after renal transplantation were logarithmically Angina pectoris was diagnosed from a typical history of transformed before use in the statistical analyses. In chest pain. Previous myocardial infarction was diagnosed by the regression analysis, patients were defined as everya history of typical chest pain and significant electrocardiographic and/or a typical acute enzymatic pattern. day smokers when using at least one cigarette per day, Cerebrovascular disease was diagnosed by a typical history and sedentary when performing less than one weekly of either a transient ischaemic attack and/or stroke with exercise session. All computations were performed on permanent clinical sequelae. Peripheral vascular disease was a personal computer (Macintosh II series, Apple diagnosed by a history of typical intermittent claudication Computers Inc., Cupertino, CA, USA) with standard with objective signs of peripheral arterial occlusive disease. statistical software (Statview 4.1 and SuperAnova, Arterial hypertension was defined as brachial artery systolic Abacus Concepts Inc., Berkeley, CA, USA, and and diastolic blood pressures above 140 and 90 mmHg, Statview 5.0, SAS Institute Inc., Cary, NC, USA).
respectively, in the sitting position on repeated sessions, and/or the need for antihypertensive medication. Sessions of moderate strenous physical activity lasting more than 25 min
Results
were registered as well as everyday cigarette smoking.
Patients transplanted before 1983 were treated conventionally with a maintenance immunosuppressive regimen com-General characteristics for the study group are given prising daily per oral prednisolone between 7.5 and 10 mg in Table 1 . Hypertension was present in almost every and azathioprine between 50 and 150 mg. Cyclosporin A and second patient ( Table 1) , and more often in males prednisolone without or with azathioprine were routinely (55%) than in females (34%, P<0.001). The patients used in patients transplanted between 1983 and 1986, whereas were, in general, hyperlipidaemic with elevated total a triple regimen with prednisolone, cyclosporin A and azacholesterol and triglyceride levels. There were 27.8%
thioprine has been in routine use for those transplanted after everyday smokers, and 36.4% were registered as 1986. Cyclosporin A was administered so that whole-blood through levels were maintained between 50 and 100 ng/ml. sedentary.
Most patients maintained their initial immunosuppressive
Ischaemic heart disease (i.e. angina pectoris and/or regimen, and were only occasionally shifted to another. previous myocardial infarction) was present in 14.2% Cardiovascular medication registered were loop-diuretics, of the patients, and the prevalence in male patients tiazides, calcium-channel antagonists, ACE inhibitors and b-was almost twice that in females ( Table 2 ). The prevaland a-adrenergic receptor blockers. The latter five were ence of angina pectoris was increased more than twoclassified as antihypertensive drugs when used on that indica-fold in the patients as compared with the general tion. At the time of this registration, lipid-lowering drugs background population which was of similar age (mean were generally not used by these patients.
age: 49.6 years). The prevalence of cerebrovascular
The prevalence of cardiovascular diseases in the general disease tended to be higher in male patients than in background population was obtained from a large contemporary national medical survey comprising 76 665 individuals females, and higher in renal transplant patients than located in mid-Norway [8] . This survey, conducted by the in the general population. The prevalence of peripheral National Institute of Public Health was designed with vascular disease was increased more than sevenfold in emphasis on hypertension, diabetes, lung-diseases and quality male patients vs females. of life. Data on cardiovascular diseases were obtained by use Of the 58 patients with ischaemic heart disease, 10 of a standardized questionnaire.
had additional peripheral vascular disease (17%), and three had cerebrovascular disease (5%). Of the 18 Odds ratios were determined by standard methods [9] . Creatinine clearance (ml/min)
Statistical analysis

60±21
Differences between groups were assessed by two-sided Systolic patients with peripheral vascular disease, 10 had evid-increased with reduced graft function ( Figure 2 ), whereas diastolic pressures did not. In patients with ence of ischaemic heart disease (56%). Of the 11 patients with cerebrovascular disease, three had isch-creatinine clearance below 30 ml/min, systolic pressures were (mean±SD) 19±4 mmHg above that in those aemic heart disease (27%).
Hypertension was significantly more prevalent in the with clearance above 80 ml/min. Age-and sex-adjusted odds ratios for angina pectoris renal transplant patients than in the general population, and more prevalent in males than in females in renal transplant patients vs the background population increased from approximately 3 in age group ( Table 2) , however, few had diastolic blood pressures above 100 mmHg ( Figure 1 ). Systolic blood pressures 60-69 years to more than 11 in age group 40-49 years ( Figure 3 ) with the highest odds ratio in the female patients aged 40-49 years. Ischaemic heart disease was significantly more prevalent in patients with diabetes ( Table 3 ) and peripheral vascular disease more prevalent in those with reduced graft function ( Table 4) . Patients using cyclosporin immunosuppression were of a similar age to those without ( Table 5 ), but had on average a significantly longer time after renal transplantation, a lower creatinine clearance, higher blood pressures and triglycerides, whereas the prevalence of cardiovascular diseases was not different between the groups.
The electrocardiograms (n=404) were classified as normal in 75%, 9% revealed left ventricular hypertrophy, 8% had signs of previous myocardial infarction and/or ischaemic changes, 4% were abnormal but with unspecific changes and 5% had arrhythmias and/or . Systolic blood pressures (SBP) in renal transplant patients diastolic blood pressures Á 90 mmHg and Á100 mmHg were present in 40.6% and 6.4%, respectively. Systolic blood pressures grouped after creatinine clearance (ml/min). Statistical significance of difference between groups: ***P<0.001 vs creatinine clearance >160 mmHg were only present in 10.8% and diastolic pressures >100 mmHg in 1.7%.
<30 ml/min; † † † P<0.001 vs creatinine clearance 30-54 ml/min. bundle branch blocks without significant gender differences. Left ventricular hypertrophy was present in 15% of the hypertensives and in 4% of the normotensives, and was equally distributed in patients with or without a cyclosporin A based immunosuppressive regimen. The prevalence of left ventricular hypertrophy 
(n=8).
On univariate analysis (Table 6 ), ischaemic heart disease was significantly related to male gender, higher borderline significant association. Peripheral vascular years of age. Thus, ischaemic heart disease apparently disease was independently and significantly related to presents in renal transplant patients approximately 20 age, male gender and systolic blood pressure, whereas years prematurely. Although the highest odds ratio for cerebrovascular disease was independently and signi-angina pectoris was found in the younger patients, the ficantly related to age only. None of the cardiovascular prevalence was indeed highest in male and female diseases were significantly associated with immuno-patients above 50 and 60 years, respectively, where suppressive regimen. almost every fourth patient had angina pectoris. This high prevalence of ischaemic heart disease was further doubled in patients with diabetes. It is therefore not Discussion surprising that mortality rates from ischaemic heart disease in patients on renal replacement therapy in The present cross-sectional study in stable renal trans-general have been reported to be up to 17-fold that in plant patients predominantly on a cyclosporin A based general population, and further raised in those with immunosuppressive regimen, demonstrates the dramat-diabetic nephropathy [3] . ically increased prevalence of ischaemic heart disease In the present study, every second patient with and hypertension as compared with the general back-peripheral vascular disease had evidence of ischaemic ground population. For example, the prevalence of heart disease, and every fourth with ischaemic heart angina pectoris in patients aged 40-49 years was disease had evidence for peripheral vascular and/or similar to that in the general population above 60 cerebrovascular disease. Other studies in patients primarily investigated for peripheral vascular disease, show Table 6 . Univariate analysis of relation between cardiovascular dis-that coronary artery disease is present in approximately eases and risk factors in renal transplant patients 60%, with three-vessel disease present in 20% [10] . In patients investigated for ischaemic heart disease, 15% IHD CBVD PVD have peripheral vascular disease [11] . These studies in
patients with apparently normal renal function, 11) together with the present study in renal transplant patients, support the clinical observation of a frequent averaging approximately 1 mmol/l above general population levels [6 ] . Total cholesterol is maintained at a IHD, Ischaemic heart disease (i.e. angina pectoris and/or previous myocardial infarction); CBVD, cerebrovascular disease; PVD, peristable and elevated level following the first months pheral vascular disease. For categorical variables amean difference post-transplantation [12] , which is caused at least between groups (ANOVA); and for continuous variables bcorrel-partially by the maintenance corticosteroid immunoational coefficients (r). Statistical significance of association between suppressive treatment [13, 14] . In a recent large followcardiovascular disease and risk factor: *P<0.05; **P<0.01; ***P<0.001. up study after renal transplantation, total cholesterol Results from multiple logistic regression analysis on the dependent variables aischaemic heart disease (i.e. angina pectoris and/or previous myocardial infarction); bcerebrovascular disease; cperipheral vascular disease, respectively. RC, Regression coefficient; SE, standard error; P, probability; R2, R squared of the respective model. and hypertension were somewhat surprisingly not iden-left ventricular mass measurements [23] , and may therefore be the preferrable method. Moreover, tified as independent risk factors for a major ischaemic heart event, whereas diabetes and HDL cholesterol echocardiographic techniques give better diagnostic accuracy of left ventricular hypertrophy than electrowere [15] . In that study, however, cyclosporine was not regularly used in maintenance immunosuppression. cardiograms [22, 24] , but are not as feasible. Finally, even though left ventricular hypertrophy is a wellRecently, the use of lipid-lowering therapy with statins in renal transplant recipients has proven effective, safe recognized independent risk factor for sudden death in the general population [25] , its implications for and well tolerated [16, 17] . On this background, there is an urgent need for results from prospective ran-cardiovascular disease in renal transplant patients have not been well defined to date. domized placebo-controlled studies of the effects of statin-mediated corrections of hyperlipidaemia on
The prevalence of ischaemic heart disease in the present study is comparable with that reported by cardiovascular morbidity and mortality after renal transplantation.
Kasiske [26 ] in a population with a similar age and sex distribution, whereas Surdacki et al.
[20] in a Systemic arterial hypertension is a well-recognized risk factor for ischaemic heart disease in the general smaller study (n=76) found a lower prevalence (8%) as could be expected since the patients were younger population, and in the present study systolic blood pressure was related to ischaemic heart disease with (mean age: 35 years). The incidence of peripheral vascular disease has previously been reported at borderline significance. Although every second patient was classified as hypertensive, blood pressure control between 3% [26 ] and 16% [27] in renal transplant patients. The former study, utilized Doppler ultrasound seemed reasonable since fewer than 15% of the patients had diastolic pressures above 90 mmHg. Patients whereas the latter was based on a patient questionnaire without clinical examination. We combined patient taking cyclosporin A were more often hypertensive as reported previously [18] . However, only 14% and 2% history and clinical examination and found 4% with peripheral vascular disease, which was independently of these patients had diastolic pressure above 90 mmHg and 100 mmHg, respectively, which is significantly and significantly related to systolic blood pressure although not to total cholesterol levels and smoking below the 15% with diastolic pressures above 100 mmHg following 2 years of renal transplantation habits. Cerebrovascular disease after renal transplantation has been found previously in 7% [26 ] , whereas reported previously [19] . Although hypertension and hypertriglyceridaemia were more frequent in patients we found a somewhat lower prevalence of 3%.
The present study is cross-sectional and the observed with cyclosporin, the prevalence of cardiovascular diseases was not different from the group of patients relations between risk factors and disease do not necessarily infer a causal relationship. However, the without. Furthermore, in the multivariate regression analysis, cyclosporin did show a significant association multivariate analysis reveals the independent strength of association between risk factors and disease, and with cardiovascular diseases. However, patients on cyclosporin had a significantly shorter time after trans-indicates where a causal relation can be sought. Thus, the strong independent association between total choplantation and most likely a shorter total history of renal failure and renal replacement as well. Thus, if lesterol and ischaemic heart disease, and that between systolic blood pressure and peripheral vascular disease, the immunosuppressive regimen was not related to the progress of cardiovascular disease, one would expect points to risk factors where a potential benefit of treatment may be expected. fewer patients with such disease in the cyclosporin group, which we did not in fact find. The present
The study patients represented 43% of the entire national population of renal transplant patients. cross-sectional study supports the theory that cardiovascular morbidity is not reduced by a cyclosporin Because a few large centres did not participate, a complete registration could not be achieved. However, based immunosuppressive regimen, however, whether morbidity actually is increased on this regimen remains the study patients covered all regions of the country and were considered representative of the entire patient to define.
In the present study, 9% of the patients had left population as indicated by the similar age and gender distribution. ventricular hypertrophy as judged from the electrocardiograms. Similar results have been reported previously Thus, in renal transplant patients the prevalence of cardiovascular diseases is raised dramatically above [20] and conform with the expected decline in left ventricular mass following renal transplantation the general population. Ischaemic heart disease and peripheral vascular disease are independently associ- [21, 22] . Of the patients classified as hypertensive, 15% had left ventricular hypertrophy. This may be due in ated with total cholesterol and systolic blood pressures, respectively, in addition to age and gender. part to effective antihypertensive treatment since fewer than 15% had diastolic blood pressures above 90 mmHg at registration. That every fourth patient
